Notice - Prescription Drug List (PDL): Hydroquinone

The purpose of this Notice of Amendment is to notify about the addition of hydroquinone or its derivatives to the Prescription Drug List (PDL) for human use when sold in concentrations greater than 2% in topical products.

Publisher

Health Canada

Resources

2

Catalogue metadata updated

2023-09-29